TechCrunch LA
DECEMBER 2, 2016
If you were to write a history of Silicon Valley, you could do it by looking at a series of major diaspora. Companies like Google, Yahoo, Oracle and PayPal attract top talent for years; when they reach maturity or a major liquidity event, their talent disperses and germinates into the next generation of companies. It’s quite possible that Snapchat could do the same for L.A.
socalTECH
DECEMBER 2, 2016
Calabasas-based surround sound and audio technology developer DTS is now officially part of Tessera , after Tessera completed its acquisition of DTS on Thursday, the companies said on Thursday afternoon. Tessera paid $850M in cash for DTS, in a deal which had originally been announced in May. Tessera said that it will introduce a new corporate name, stock ticker, brand, and logo during the first quarter of 2017 as a result of the acquisition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
L.A. Business Journal
DECEMBER 2, 2016
Bam Venture Partners has started raising a second $30 million fund which it will use, in part, to invest in and incubate startup ideas thought of by Brian Lee, co-founder of the fund and chief executive of the Honest Co. of Playa Vista. What capital isn’t used for the incubator will be invested in seed and early stage deals, similar to the sort of investments made by the first Bam Ventures fund, said Lee.
socalTECH
DECEMBER 2, 2016
A new, San Diego startup, ClipCast , has launched a new mobile app which lets users capture multiple video views from different smartphones, from different angles. According to ClipCast, its new app, which runs on both iOS and Android, allows usres to produce multiple point-of-view video highlights, which can be captured, edited, and shared with others in real time.
Advertiser: Aggregage
Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.
L.A. Business Journal
DECEMBER 2, 2016
Bam Ventures launches incubator for Brian Lee’s ideas, Bankrupt Nasty Gal may have a suitor, Annapurna Pictures launches video game division, and more.
socalTECH
DECEMBER 2, 2016
Huntington Beach-based Olloclip , which makes add-on lenses for the iPhone, is launching its own pop-up store and image gallery this holiday season, with a store in LA's Fairfax district. According to Olloclip, it will have a pop-up shop in LA, at the Seventh Letter Gallry on North Fairfax Ave, which will showcase photos taken with its lenses, as well as product demos and a shop.
Southern California Tech Central brings together the best content for technical professionals in Southern California from the widest variety of industry thought leaders.
socalTECH
DECEMBER 2, 2016
Los Angeles-based Joymode , the new startup led by Joe Fernandez which is hoping to people to invest in experiences, not stuff , is hoping to show off its new service with a pop-up shop in Sunset Junction next week. Joymode says it will be opening up to the public next Wednesday, on December 7th, showing off all of the experiences offered up through the service.
SoCal Tech Calendar
DECEMBER 2, 2016
Thursday, December 8, 2016 -- WITI Holiday Mix and Mingle! Please join WITI Los Angeles for a Holiday MandM (Mix and Mingle)! A relaxing evening of networking event to celebrate the wonderful year WITI Los Angeles has shared with all of you! Many families live in poverty and are unable to provide gifts for their Children! Let's Celebrate the 1 year of the WITI Los Angeles Re-Launch with a Charitable Donation to our Community.
socalTECH
DECEMBER 2, 2016
Los Angeles-based online ticketing and movie service Fandango continues to be in an acquisitive move, and has acquired Latin American online movie ticketer Cinepapaya. Financial terms of the acquisition were not announced. The acquisition follows an acquisition last year of Brazilian ticketing firm Ingresso.com. Fandango said the buy doubles its reach in Latin America.
Xconomy
DECEMBER 2, 2016
Connect, the San Diego nonprofit supporting local innovation and entrepreneurship, handed out its Most Innovative New Product Awards at a dinner last night in La Jolla—recognizing innovations that range from an inflatable satellite antenna to a mobile app for art museums. Volunteer entrepreneurs, investors, and business executives evaluated 111 nominations in eight categories for the 29th annual awards.
Startup Professionals Musings
DECEMBER 2, 2016
Focus is everything in a business, whether it be a new startup or a large enterprise. In my role as a business advisor, I often see well-meaning entrepreneurs try to be everything to everyone, which results in many things done poorly, and few totally delighted customers. People are confused by multiple messages, and employees are frustrated trying to personalize customer experiences.
Xconomy
DECEMBER 2, 2016
As we fly over Cuba en route from Fort Lauderdale to Medellin, I am already imbibing the upcoming culture change from the happy chaos at the departure gate in Florida. The plane is surprisingly not full and my fellow passengers, primarily Hispanics, are in a sleepy good mood. We will be arriving at 1am and I have to navigate a taxi or Uber to the hotel.
Xconomy
DECEMBER 2, 2016
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease. Lilly wasn’t alone, however. Several companies, among them Juno Therapeutics, Arrowhead Pharmaceutials, and Nivalis Therapeutics, have had some bad news for investors of late, sinking share prices and reminding folks just how quickly things can go south in biotech.
Xconomy
DECEMBER 2, 2016
Healthcare news has been coming fast and furious in the fallout of the election, particularly this week. Read on below for the latest on the 21st Century Cures Act, the Trump Administration’s latest nominees, and a biopharma CEO’s warning to his peers on drug pricing. IN WASHINGTON… —The House of Representatives passed a sweeping healthcare bill, the 21st Century Cures Act, by a wide 392-26 vote , a rebuke to critics who say the bill does nothing to stem high drug prices and will unwind FD
Expert insights. Personalized for you.
307 
Let's personalize your content